Bain, Cinven to acquire specialty chemicals maker for $4.7bn

Private equity specialists Bain Capital and Cinven inked a deal to purchase the Specialty Ingredients unit (LSI) of Switzerland-based pharmaceuticals group Lonza for an enterprise value of CHF4 . . .

Continue Reading With a Free Trial

Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.

Already a subscriber? Log in.

Related Articles

Back to top button

Get our daily news digest
in your inbox

Our FREE mailing list brings you daily alts intel.

Thank you for subscribing.

Something went wrong.